Annals of Medicine
Volume 54, 2022 - Issue 1
Open access
3,283
Views
5
CrossRef citations to date
0
Altmetric
Oncology
Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapy
Min Denga Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China;b State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
, Shaohua Lia Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China;b State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
, Qiaoxuan Wangb State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China;c Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
, Rongce Zhaoa Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China;b State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
, Jingwen Zoua Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China;b State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
, Wenping Lina Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China;b State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
, Jie Meia Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China;b State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
, Wei Weia Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China;b State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, ChinaCorrespondence[email protected]
& Rongping Guoa Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China;b State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, ChinaCorrespondence[email protected]
show all
Pages 803-811
|
Received 11 Sep 2021, Accepted 27 Feb 2022, Published online: 11 Mar 2022
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.